/
BLFS
$35.23+$0.26 (+0.74%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.7B
49M shares
52-week range
$17.86 – $35.35
99% from low
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Exchange
NASDAQ
CS
Change$-10.42
BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
www.biolifesolutions.com- Employees
- 155
- IPO / List date
- Nov 22, 1989
- HQ
- BOTHELL, WA
Held by traders on TradeandTell
No one on the platform currently holds BLFS.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 207,128 | $4.0M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2014-01-29 | 1-for-14reverse |
Recent trades on TradeandTell
No one on the platform has traded BLFS yet.
